研究单位:[1]Binhui Biopharmaceutical Co., Ltd.[2]Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology,Wuhan,Hubei,China,430000
An open-label dose-escalation phase I clinical study to evaluate the safety, tolerability and pharmacokinetics of OH2 injection via transcatheter Intraarterial infusion in patients with advanced hepatocellular carcinoma